<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Foo GW</submitter><funding>Canadian Institutes of Health Research</funding><pagination>3696-3708</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12455656</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(9)</volume><pubmed_abstract>Imbalances in the mammalian gut are associated with acute and chronic conditions, and using engineered probiotic strains to deliver synthetic constructs to treat them is a promising strategy. However, high rates of mutational escape and genetic instability &lt;i>in vivo&lt;/i> limit the effectiveness of biocontainment circuits needed for safe and effective use. Here, we describe STALEMATE (&lt;b>S&lt;/b>equence en&lt;b>TA&lt;/b>ng&lt;b>LE&lt;/b>d &lt;b>M&lt;/b>ulti l&lt;b>A&lt;/b>yered gene&lt;b>T&lt;/b>ic buff&lt;b>E&lt;/b>ring), a dual-layered failsafe biocontainment strategy that entangles genetic sequences to create pseudoessentiality and buffer against mutations. We entangled the colicin E9 immunity protein (Im9) with a thermoregulated meganuclease (TSM) by overlapping the reading frames. Mutations that disrupted this entanglement </pubmed_abstract><journal>ACS synthetic biology</journal><pubmed_title>Genetic Entanglement Enables Ultrastable Biocontainment in the Mammalian Gut.</pubmed_title><pmcid>PMC12455656</pmcid><funding_grant_id>PJT 191939</funding_grant_id><pubmed_authors>Uruthirapathy AS</pubmed_authors><pubmed_authors>Heinrichs DE</pubmed_authors><pubmed_authors>Zhang CQ</pubmed_authors><pubmed_authors>Edgell DR</pubmed_authors><pubmed_authors>Foo GW</pubmed_authors><pubmed_authors>Batko IZ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genetic Entanglement Enables Ultrastable Biocontainment in the Mammalian Gut.</name><description>Imbalances in the mammalian gut are associated with acute and chronic conditions, and using engineered probiotic strains to deliver synthetic constructs to treat them is a promising strategy. However, high rates of mutational escape and genetic instability &lt;i>in vivo&lt;/i> limit the effectiveness of biocontainment circuits needed for safe and effective use. Here, we describe STALEMATE (&lt;b>S&lt;/b>equence en&lt;b>TA&lt;/b>ng&lt;b>LE&lt;/b>d &lt;b>M&lt;/b>ulti l&lt;b>A&lt;/b>yered gene&lt;b>T&lt;/b>ic buff&lt;b>E&lt;/b>ring), a dual-layered failsafe biocontainment strategy that entangles genetic sequences to create pseudoessentiality and buffer against mutations. We entangled the colicin E9 immunity protein (Im9) with a thermoregulated meganuclease (TSM) by overlapping the reading frames. Mutations that disrupted this entanglement </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-07-15T05:51:43.016Z</modification><creation>2026-06-30T03:16:03.472Z</creation></dates><accession>S-EPMC12455656</accession><cross_references><pubmed>40914949</pubmed><doi>10.1021/acssynbio.5c00412</doi></cross_references></HashMap>